ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1675

Regional Implantation of Adipose Tissue-Derived Cells Induces a Prompt Healing of Long-Lasting Indolent Digital Ulcers in Patients with Systemic Sclerosis

Nicoletta Del Papa1, Gabriele Di Luca2, Domenico Sambataro1,3, Eleonora Zaccara4, Wanda Maglione4, Armando Gabrielli5, Paolo Fraticelli6, Gianluca Moroncini5, Lorenzo Beretta7,8, Alessandro Santaniello9 and Claudio Vitali10, 1Rheumatology Unit, Istituto G.Pini, Milan, Italy, 2UOS Chirurgia Vascolare,, Osp. G. Pini, Milano, Italy, 3UOC Day Hospital Reumatologia,, G. Pini Hospital, Milano, Italy, 4U.O.C. Day Hospital Reumatologia, Osp. G. Pini, Milano, Italy, 5Scienze Cliniche e Molecolari, Università Politecnica delle Marche, Ancona, Italy, 6Dipartimento di Scienze Cliniche e Molecolari, Clinica Medica, Università Politecnica delle Marche, Ancona, Italy, 7Via Francesco Sforza 28, Ospedale Maggiore Policlinico, Milano, Italy, 8Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy, 9Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy, 10Sezione Reumatologia, Istituto San Giuseppe, Lecco, Italy

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: adipose tissue, Stem cells, systemic sclerosis and ulcers

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics: Systemic Sclerosis, Diagnostic and Therapeutic Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose

Fingertip digital ulcers (DUs) are a rather frequent and invalidating complication in the course of systemic sclerosis (SSc), often showing a very slow or null tendency to heal, and causing intense local pain. Furthermore, most of the commonly used systemic and local therapeutic procedures have demonstrated to be scarcely or totally inadequate to induce a rapid healing in the SSc-related DUs. Recently stem cell therapy has emerged as a new approach to accelerate wound healing, and some case reports have been published where local or regional transfer of bone marrow stem cells (BMSCs) was effective in improving or healing SSc-related ischemic lesions. Adipose-derived stem cells (ASCs) are considered another source of multipotent stem cells potentially able to induce angiogenesis and tissue repair.In the present study we have tentatively treated long lasting and poorly responsive to traditional therapy SSc-related DUs by the implantation of autologous adipose-tissue derived cells (ATDCs) fraction, that it know to contains both the ASCs and the stromal/vascular cell (SV) component.

Methods

Fifteen patients with SSc having a long lasting DU in only one fingertip, unresponsive  to intensive systemic and local treatment, were enrolled into the study. The grafting procedure consisted in the injection, at the basis of the corresponding finger, of 0.5-1 ml of ATDCs fraction, separated by centrifugation of adipose tissue collected through liposuction from subcutaneous abdominal fat. Time to healing after the procedure was the primary end point of the study, while reduction of pain intensity (measured by visual analogue scale), and of analgesic consumption represented secondary end point. Furthermore, the after therapy variation of the number of capillaries, observed in the nailfold video-capillaroscopy (NVC) exam, and of the resistivity in the digit arteries, measured by high resolution echo-color doppler were also taken into account.

Results

A rather speed healing of the DUs was reached in all of the enrolled patients (mean time to healing 4.23 weeks; range 3-8 weeks).  A significant reduction of pain intensity was observed after few weeks (p<0.001), while the number of capillaries was significantly increased at second (3 months) and third (6 months) NVC assessment (p<0.0001 in both cases, with respect to the basal examination). Finally, a significant after treatment reduction of digit artery resistivity was also recorded (p<0.0001).

Conclusion

Even with the limitations related to the small number of patients included, and to the open-label design of the study, the strongly favourable outcome we observed suggests that the local grafting with ATDC, containing both ASCs and SV fraction, could represent a promising option for the treatment of SSc-related DUs unresponsive to more consolidated therapies.


Disclosure:

N. Del Papa,
None;

G. Di Luca,
None;

D. Sambataro,
None;

E. Zaccara,
None;

W. Maglione,
None;

A. Gabrielli,
None;

P. Fraticelli,
None;

G. Moroncini,
None;

L. Beretta,
None;

A. Santaniello,
None;

C. Vitali,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/regional-implantation-of-adipose-tissue-derived-cells-induces-a-prompt-healing-of-long-lasting-indolent-digital-ulcers-in-patients-with-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology